Wednesday, March 17, 2010

FDA Clueless About Osteoporosis Drugs

The FDA announced on 3.10.2010 that there was no “clear connection” between bisphosphonate (e.g., Fosamax, Zometa, Boniva, and Didroneo) use and femur fracture risk.  The agency had no evidence to conclude that osteoporosis drugs increase the risk of femur fractures just below the hip joint.  The FDA stated, “At this point, the data that FDA has reviewed have not shown a clear connection between bisphosphonate use and a risk of atypical subtrochanteric femur fractures.” 
I hope you feel better about the FDA’s statements.  I don’t.
The FDA is reacting to an ABC News story citing “mounting evidence” showing that long-term use of Fosamax could cause spontaneous femur fractures in women.    The New England Journal of Medicine has reported case histories of spontaneous fractures of the femur in women taking bisphosphonate drugs.  These case histories claimed the women who fractured their femur either had a minor impact to  the leg or no trauma; the bone just fractured.  Remember, this is the largest and strongest bone in the body.  The femur should not spontaneously fracture—EVER!
The FDA is clueless here.  The most commonly prescribed osteoporosis drugs work by poisoning bone cells.  As I wrote in my book, Drugs That Don’t Work and Natural Therapies That Do, “You can’t poison an important enzyme for the long term and expect a good result.”   I say spontaneous femur fractures should be predicted in those that use bisphosphonate drugs.    
Here’s an idea for the health care plan; get rid of the FDA.  They are not looking out for us, the citizens.  They look out for the Big Pharma Cartel.  We could save a lot of money just dismantling the FDA.  That money could insure a lot of Americans. 
No one should take a bisphosphonate drug for any condition.  If you have osteoporosis, there are many safe and effective natural therapies available to you. 


Post a Comment

Subscribe to Post Comments [Atom]

<< Home